Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals

Shadpour Demehri, M. Samini, K. Namiranian, H. Rastegar, S. E. Mehr, H. Homayoun, F. Roushanzamir, M. Jorjani, A. R. Dehpour

Research output: Contribution to journalArticle

Abstract

1 Our previous report showed that in acute cholestasis, the subsensitivity to morphine inhibitory effect on electrical-stimulated contractions develops significantly faster in guinea-pig ileum (GPI) and in mouse vas deferens (MVD) (45.2 and 29.9 times, respectively) compared with non-cholestatic subjects. 2 The possible contribution of α2-adrenoceptor and nitric oxide (NO) pathways on the development of tolerance was assessed in GPI and MVD of cholestatic subjects. 3 Daily administration of naltrexone (20 mg kg -1), yohimbine (5 mg kg-1), and Nω -nitro-L-arginine methyl ester (L-NAME) (3 mg kg-1) to cholestatic animals significantly (P-value <0.05) inhibited the process of subsensitivity in all groups. 4 Consistent with the literature, it was concluded that both the α2-adrenergic system and NO have close interaction with the opioid system and may underlie some of the mechanisms involved in the subsensitivity development to opioids in acute cholestatic states.

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalAutonomic and Autacoid Pharmacology
Volume23
Issue number4
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Vas Deferens
Ileum
Adrenergic Receptors
Opioid Analgesics
Nitric Oxide
Guinea Pigs
Naltrexone
Yohimbine
Cholestasis
NG-Nitroarginine Methyl Ester
Adrenergic Agents
Morphine
arginine methyl ester

Keywords

  • α-adrenoceptors
  • Cholestasis
  • Guinea-pig ileum
  • Mice vas deferens
  • Nitric oxide

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals. / Demehri, Shadpour; Samini, M.; Namiranian, K.; Rastegar, H.; Mehr, S. E.; Homayoun, H.; Roushanzamir, F.; Jorjani, M.; Dehpour, A. R.

In: Autonomic and Autacoid Pharmacology, Vol. 23, No. 4, 08.2003, p. 201-207.

Research output: Contribution to journalArticle

Demehri, S, Samini, M, Namiranian, K, Rastegar, H, Mehr, SE, Homayoun, H, Roushanzamir, F, Jorjani, M & Dehpour, AR 2003, 'Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals', Autonomic and Autacoid Pharmacology, vol. 23, no. 4, pp. 201-207. https://doi.org/10.1046/j.1474-8673.2003.00297.x
Demehri, Shadpour ; Samini, M. ; Namiranian, K. ; Rastegar, H. ; Mehr, S. E. ; Homayoun, H. ; Roushanzamir, F. ; Jorjani, M. ; Dehpour, A. R. / Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals. In: Autonomic and Autacoid Pharmacology. 2003 ; Vol. 23, No. 4. pp. 201-207.
@article{1c4a19c495ce4a0ba6b533b849e3d469,
title = "Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals",
abstract = "1 Our previous report showed that in acute cholestasis, the subsensitivity to morphine inhibitory effect on electrical-stimulated contractions develops significantly faster in guinea-pig ileum (GPI) and in mouse vas deferens (MVD) (45.2 and 29.9 times, respectively) compared with non-cholestatic subjects. 2 The possible contribution of α2-adrenoceptor and nitric oxide (NO) pathways on the development of tolerance was assessed in GPI and MVD of cholestatic subjects. 3 Daily administration of naltrexone (20 mg kg -1), yohimbine (5 mg kg-1), and Nω -nitro-L-arginine methyl ester (L-NAME) (3 mg kg-1) to cholestatic animals significantly (P-value <0.05) inhibited the process of subsensitivity in all groups. 4 Consistent with the literature, it was concluded that both the α2-adrenergic system and NO have close interaction with the opioid system and may underlie some of the mechanisms involved in the subsensitivity development to opioids in acute cholestatic states.",
keywords = "α-adrenoceptors, Cholestasis, Guinea-pig ileum, Mice vas deferens, Nitric oxide",
author = "Shadpour Demehri and M. Samini and K. Namiranian and H. Rastegar and Mehr, {S. E.} and H. Homayoun and F. Roushanzamir and M. Jorjani and Dehpour, {A. R.}",
year = "2003",
month = "8",
doi = "10.1046/j.1474-8673.2003.00297.x",
language = "English (US)",
volume = "23",
pages = "201--207",
journal = "Autonomic and Autacoid Pharmacology",
issn = "1474-8665",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Alpha2-adrenoceptor and NO mediate the opioid subsensitivity in isolated tissues of cholestatic animals

AU - Demehri, Shadpour

AU - Samini, M.

AU - Namiranian, K.

AU - Rastegar, H.

AU - Mehr, S. E.

AU - Homayoun, H.

AU - Roushanzamir, F.

AU - Jorjani, M.

AU - Dehpour, A. R.

PY - 2003/8

Y1 - 2003/8

N2 - 1 Our previous report showed that in acute cholestasis, the subsensitivity to morphine inhibitory effect on electrical-stimulated contractions develops significantly faster in guinea-pig ileum (GPI) and in mouse vas deferens (MVD) (45.2 and 29.9 times, respectively) compared with non-cholestatic subjects. 2 The possible contribution of α2-adrenoceptor and nitric oxide (NO) pathways on the development of tolerance was assessed in GPI and MVD of cholestatic subjects. 3 Daily administration of naltrexone (20 mg kg -1), yohimbine (5 mg kg-1), and Nω -nitro-L-arginine methyl ester (L-NAME) (3 mg kg-1) to cholestatic animals significantly (P-value <0.05) inhibited the process of subsensitivity in all groups. 4 Consistent with the literature, it was concluded that both the α2-adrenergic system and NO have close interaction with the opioid system and may underlie some of the mechanisms involved in the subsensitivity development to opioids in acute cholestatic states.

AB - 1 Our previous report showed that in acute cholestasis, the subsensitivity to morphine inhibitory effect on electrical-stimulated contractions develops significantly faster in guinea-pig ileum (GPI) and in mouse vas deferens (MVD) (45.2 and 29.9 times, respectively) compared with non-cholestatic subjects. 2 The possible contribution of α2-adrenoceptor and nitric oxide (NO) pathways on the development of tolerance was assessed in GPI and MVD of cholestatic subjects. 3 Daily administration of naltrexone (20 mg kg -1), yohimbine (5 mg kg-1), and Nω -nitro-L-arginine methyl ester (L-NAME) (3 mg kg-1) to cholestatic animals significantly (P-value <0.05) inhibited the process of subsensitivity in all groups. 4 Consistent with the literature, it was concluded that both the α2-adrenergic system and NO have close interaction with the opioid system and may underlie some of the mechanisms involved in the subsensitivity development to opioids in acute cholestatic states.

KW - α-adrenoceptors

KW - Cholestasis

KW - Guinea-pig ileum

KW - Mice vas deferens

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=2342642683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342642683&partnerID=8YFLogxK

U2 - 10.1046/j.1474-8673.2003.00297.x

DO - 10.1046/j.1474-8673.2003.00297.x

M3 - Article

VL - 23

SP - 201

EP - 207

JO - Autonomic and Autacoid Pharmacology

JF - Autonomic and Autacoid Pharmacology

SN - 1474-8665

IS - 4

ER -